Affordable Access

Access to the full text

In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments

Authors
  • monnier, philippe
  • vigouroux, robin
  • tassew, nardos
Publication Date
Apr 11, 2013
Identifiers
DOI: 10.3390/antib2020193
OAI: oai:mdpi.com:/2073-4468/2/2/193/
Source
MDPI
Keywords
Language
English
License
Green
External links

Abstract

Single chain variable domain (Fv) fragments (scFv) are powerful tools in research and clinical settings, owing to better pharmacokinetic properties compared to the parent monoclonal antibodies and the relative ease of producing them in large quantities, at low cost. Though they offer several advantages, they suffer from lower binding affinity and rapid clearance from circulation, which limits their therapeutic potential. However, these fragments can be genetically modified to enhance desirable properties, such as multivalency, high target retention and slower blood clearance, and as such, a variety of scFv formats have been generated. ScFvs can be administered by systemic injection for diagnostic and therapeutic purposes. They can be expressed in vivo through viral vectors in instances where large infection rates and sustenance of high levels of the antibody is required. ScFvs have found applications as tools for in vivo loss-of-function studies and inactivation of specific protein domains, diagnostic imaging, tumor therapy and treatment for neurodegenerative and infectious diseases. This review will focus on their in vivo applications.

Report this publication

Statistics

Seen <100 times